| Literature DB >> 28288111 |
Junlei Chang1, Michael R Mancuso1, Carolina Maier2, Xibin Liang3, Kanako Yuki1, Lu Yang4, Jeffrey W Kwong1, Jing Wang3, Varsha Rao5, Mario Vallon1, Cynthia Kosinski1, J J Haijing Zhang1, Amanda T Mah1, Lijun Xu6, Le Li6, Sharareh Gholamin2, Teresa F Reyes1, Rui Li7, Frank Kuhnert1, Xiaoyuan Han8, Jenny Yuan1, Shin-Heng Chiou5, Ari D Brettman1, Lauren Daly1, David C Corney1, Samuel H Cheshier2, Linda D Shortliffe8, Xiwei Wu4, Michael Snyder5, Pak Chan2, Rona G Giffard6, Howard Y Chang7,9, Katrin Andreasson3, Calvin J Kuo1.
Abstract
Although blood-brain barrier (BBB) compromise is central to the etiology of diverse central nervous system (CNS) disorders, endothelial receptor proteins that control BBB function are poorly defined. The endothelial G-protein-coupled receptor (GPCR) Gpr124 has been reported to be required for normal forebrain angiogenesis and BBB function in mouse embryos, but the role of this receptor in adult animals is unknown. Here Gpr124 conditional knockout (CKO) in the endothelia of adult mice did not affect homeostatic BBB integrity, but resulted in BBB disruption and microvascular hemorrhage in mouse models of both ischemic stroke and glioblastoma, accompanied by reduced cerebrovascular canonical Wnt-β-catenin signaling. Constitutive activation of Wnt-β-catenin signaling fully corrected the BBB disruption and hemorrhage defects of Gpr124-CKO mice, with rescue of the endothelial gene tight junction, pericyte coverage and extracellular-matrix deficits. We thus identify Gpr124 as an endothelial GPCR specifically required for endothelial Wnt signaling and BBB integrity under pathological conditions in adult mice. This finding implicates Gpr124 as a potential therapeutic target for human CNS disorders characterized by BBB disruption.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28288111 PMCID: PMC5559385 DOI: 10.1038/nm.4309
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 87.241